Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, announced new ...
Odds for developing Parkinson’s disease increased with newer groundwater and with carbonate aquifers, according to a poster ...
Rare neurological disease has undergone a meaningful shift over the past decade. Advances in human genetics, expanded access ...
New registry connects patients and researchers to accelerate understanding and improve care in autoimmune neurological diseases ...
Parkinson's disease is one of the most common neurological diseases found in older men. Marked by a steady decline in ...
Football players experienced nearly one out of every five traumatic brain injuries among youth athletes, according to a ...
Neurological disorders represent a highly complex area within medicine, characterized by multifactorial etiologies involving disruptions across numerous ...
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) said on Tuesday an abstract from its mid-stage study of experimental Parkinson’s ...
In September last year, we reported Servier had advanced its emerging neurology pipeline into the clinical trials stage by ...
An international research team with the participation of researchers from the University Medical Center Göttingen (UMG), ...
BioVie Inc. (NASDAQ: BIVI) ('BioVie” or the 'Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced the acceptance of ...
Long COVID was associated with an increased risk for cardiovascular disease and other major cardiovascular events. HealthDay News — Individuals with long COVID have an increased risk for developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results